Corient IA’s Lam Research LRCX Stock Holding History

Corient IA’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$867K	Sell	2,000 -750	-27%	-$228K	0.8%	35
2026 Q1	$588K	Buy	+2,750	New	+$615K	0.55%	37

Other funds holding LRCX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Corient IA's LRCX Position: Q2 2026 in Review

Corient IA reduced its Lam Research (LRCX) stake by 27% in Q2 2026, selling an estimated $228K and leaving 2,000 shares worth $867K. The position accounts for 0.8% of the portfolio, ranked #35.

Corient IA first reported a position in LRCX in Q1 2026 and has held it in 2 quarters since. 3,122 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

Corient IA held 2,000 shares of Lam Research worth $867K as of Q2 2026.
Corient IA sold 750 Lam Research shares in Q2 2026, an estimated $228K.
Lam Research made up 0.8% of Corient IA's portfolio in Q2 2026, its #35 holding.
Corient IA first reported a position in Lam Research in Q1 2026 and has held it in 2 quarters since.
3,122 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Corient IA's 13F filing for Q2 2026, filed 12 Aug 2026.